The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abnormal in vivo metabolism of apolipoprotein E4 in humans.
Open accessAbstract
Apolipoprotein E (apoE) is important in modulating the catabolism of remnants of triglyceride-rich lipoprotein particles. It is a polymorphic protein with the three common alleles coding for apoE2, apoE3, and apoE4. ApoE3 is considered the normal isoform, while apoE4 is associated both with hypercholesterolemia and type V hyperlipoproteinemia. We quantitated the kinetics of metabolism of apoE4 in 19 normolipidemic apoE3 homozygotes and 1 normolipidemic apoE4 homozygote, and compared this with the metabolism of apoE3 in 12 normolipidemic apoE3 homozygotes. In the apoE3 homozygous subjects, apoE4 was catabolized twice as fast as apoE3, with a mean plasma residence time of 0.37 +/- 0.01 d (+/- SEM) and 0.73 +/- 0.05 (P less than 0.001), respectively. When plasma was fractionated into the lipoprotein subclasses, the greatest amount of labeled apoE4 was present on very low density lipoproteins, while the largest fraction of labeled apoE3 was associated with high density lipoproteins. The plasma apoE concentration was decreased in an apoE4 homozygote compared with the apoE3 homozygotes (3.11 mg/dl vs. 4.83 +/- 0.35 mg/dl). The reduced apoE4 concentration was entirely due to a decreased apoE4 residence time in the apoE4 homozygote (0.36 d vs. 0.73 +/- 0.05 d for apoE3 in apoE3 homozygotes). These results indicate that apoE4 is kinetically different than apoE3, and suggest that the presence of apoE4 in hypercholesterolemic and type V hyperlipoproteinemic individuals may play an important pathophysiological role in the development of these dyslipoproteinemias.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In humans and animal models, apoE genotype is correlated with apoE protein levels in plasma, with 2 showing the highest protein levels and 4 the lowest (Eto et al., 1986;Gregg et al., 1986;Raffai et al., 2001) (Fig. 2).”
From Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels (2008) · cites this paper as Gregg et al., 1986
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“where ApoE4 is catabolized twice as fast as ApoE3 [15].”
From In Vivo Human Apolipoprotein E Isoform Fractional Turnover Rates in the CNS (2012) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“Despite near-normal receptor affinity of apoE4 the amino acid change leads to differences in distribution in lipoprotein classes: apoE3 shows preference for high density lipoprotein (HDL) particles, whereas apoE4 shows preference for very low density lipoprotein (VLDL) particles [38].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [38]
The cited source says what the claim attributes to it.
In the citing paper
“Early work showed that, in the blood, APOE4 preferentially associates with VLDL, whereas APOE3 displays a preference for HDL (Gregg et al., 1986;Steinmetz et al., 1989;Weisgraber, 1990).”
From Isoform- and cell-state-specific lipidation of ApoE in astrocytes (2022) · cites this paper as Gregg et al., 1986
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,737
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,154
Lipid Research Clinics Program
Renfrew, R. A. (1984) · JAMA · doi:10.1001/jama.1984.03350180015009 · Cited by 829
Lipoprotein receptors and cholesterol homeostasis
Mahley, R. W., & Innerarity, T. L. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90001-1 · Cited by 756
Human apolipoprotein E. The complete amino acid sequence
Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34702-1 · Cited by 741
Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34954-8 · Cited by 673
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Polymorphism of apolipoprotein E
Utermann, G., Vogelberg, K. H., Steinmetz, A., Schoenborn, W., Pruin, N., Jaeschke, M., Hees, M. T. I. W. S.-V., & Canzler, H. (1979) · Clinical Genetics · doi:10.1111/j.1399-0004.1979.tb02027.x · Cited by 408
Utermann, G., Jaeschke, M., & Menzel, J. (1975) · FEBS Letters · doi:10.1016/0014-5793(75)81125-2 · Cited by 337
Packard, C. J., Munro, A. F., Lorimer, A. R., Gotto, A. M., & Shepherd, J. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111644 · Cited by 298
Flagged first, then by citations
Research works printed but not linked: 1
- [13]13. Gregg, R. E., D. Wilson, E. Rubalcaba, R. Ronan, and H. B. Brewer, Jr. 1983. Immunoquantitation of apolipoprotein E. Proc. Workshop Apolipoprotein Quantitation. 383–401.
Cited by
Sorted by citations
Items 301–344 of 344
Hamaguchi, K., Arikawa, M., Yasunaga, S., Kakuma, T., Fukagawa, K., Yanase, T., Nawata, H., & Sakata, T. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980226)76:1 · Cited by 18
Strategies to Protect the Brain During Cardiac Surgery
Newman, M. F., Stanley, T. O., & Grocott, H. P. (2000) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1053/vc.2000.6499 · Cited by 3
Feng, J., Wan, G., Zhu, X., Wang, B., & Yang, Z. (2010) · Asian Biomedicine · doi:10.5372/5092 · Cited by 2
King, R. I., & Brennan, S. O. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.03.021 · Cited by 2
Apolipoprotein E Polymorphism in Sheep
Tsunoda, K., Yamamoto, Y., Akiya, Y., Sato, K., RAJBHANDARY, H. B., Son, H. V., & Loc, C. B. (1998) · Biochemical Genetics · doi:10.1023/a:1018753714783 · Cited by 2
Apolipoprotein Variation: Effect on Plasma Lipid Variability
Utermann, G. (1989) · Springer eBooks · doi:10.1007/978-1-4615-9549-6_2 · Cited by 1
ApoE phenotype influences plasma ASP in hyperapoB subjects
Cianflone, K. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00289-2 · Cited by 2
Apolipoprotein-ε4 (APOE) Gene Is a Risk Factor for Human Coronary Artery Disease
Hazarika, L., & Sen, S. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_61-1 · Cited by 1
Lipoproteins and Apolipoproteins of the Ageing Eye
Loane, E. (2012) · InTech eBooks · doi:10.5772/45985 · Cited by 1
Genetic Risk Factors: Their Function and Comorbidities in Alzheimer′s Disease
Hiltunen, M. O., Bertram, L., & Saunders, A. J. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/925362 · Cited by 1
Genes implicados en la hiperlipemia familiar combinada
López‐Ruiz, A., Martínez-Triguero, M. L., Morillas-Ariño, C., & Mijares, A. H. (2006) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(06)73659-2 · Cited by 1
Stephens, G. S., You, J. C., Fu, C.-H., & Chin, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.21126-7 · Cited by 1
Vascular Inflammation and Genetic Predisposition as Risk Factors for Cardiovascular Diseases
Gungor, Z. B. (2018) · InTech eBooks · doi:10.5772/intechopen.76016 · Cited by 1
The Role of Genetics in Preventive Cardiology: Utility of Clinically Available Genetic Tests
Superko, H. R. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56279-3_15 · Cited by 1
Postprandial redistribution of apo E isoforms in triglyceride-rich lipoproteins
Richter, G., Schwarz, S., Manthey, T., Ehlenz, K., Kaffarnik, H., & Steinmetz, A. (1993) · Vieweg+Teubner eBooks · doi:10.1007/978-3-663-01942-8_12 · Cited by 1
Potential Biological Mechanisms of ApoE in Alzheimer’s Disease
Rebeck, G. W. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_2 · Cited by 1
Ikeuchi, R., SAKUMA, N., Hasegawa, Y., Hibino, T., Yoneyama, A., Tamai, N., Sasai, K., & Yoshimata, T. (1997) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.23.187 · Cited by 1
Yang, L., Liu, Y.-Z., Forte, T., Chisholm, J. W., Parks, J., & Shachter, N. (2003) · doi:10.2172/886608
Molecular Genetics Approach to Polygenic Disease—Initial Results from Atherosclerosis Research
Funke, H., von Eckardstein, A., & Assmann, G. (1991) · Springer eBooks · doi:10.1007/978-1-4615-3690-1_3 · Cited by 1
Grandl, M. (2006) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.10433 · Cited by 1
Mechanisms underlying the atherosclerosis risk associated with apolipoprotein E isoforms in humans
Altenburg, M. K. (2007) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/c6pc-dx08
The Role of Apolipoprotein E Concentration and Isoform in Amyloid-beta Metabolism In Vivo
Castellano, J. M. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7416v3s
Regulierung und Verfügbarkeit von Apolipoprotein E in Astrozyten
Hamker, U. (2005) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/15272
Zannis, V. I., Laccotripe, M., Makrides, S. C., Kardassis, D., & Zanni, E. E. (1996) · Springer eBooks · doi:10.1007/978-1-4613-0355-8_7
Polymorphism of Apolipoprotein E
Kim, C. J. (1997) · Korean Circulation Journal · doi:10.4070/kcj.1997.27.3.275
Apolipoprotéines et métabolisme plasmatique des lipoprotéines
Couderc, R., Dehoux, M., & Tallet, F. (1988) · Nutrition Clinique et Métabolisme · doi:10.1016/s0985-0562(88)80020-7
Gregg, R. E., Zech, L. A., Gabelli, C., Hoeg, J. M., & Brewer, H. B. (1987) · Springer eBooks · doi:10.1007/978-1-4684-5296-9_11
Self-citationThe high- and low-activity forms of human plasma phospholipid transfer protein (PLTP)
Jänis, M. T. (2006) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)
Liberopoulos, E. N., Miltiadous, G. A., Hatzivassiliou, M., Pasiardi, I., Tsimihodimos, V., Bairaktari, E. T., Cariolou, M. A., & Elisaf, M. (2004) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(04)90232-8
Association of Apolipoprotein E Genotype with Early and Advanced Atherosclerotic Lesions
Ilveskoski, E. (2001) · Tampere University Institutional Repository (Tampere University)
McGladdery, S. H. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0089570
Ball, G. F. M. (2004) · VITAMINS · doi:10.1002/9780470774571.ch10
Carrasquillo, M. M., Bu, G., & Nielsen, H. M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7309-1_2
Meyer, B. J. (2018) · MDPI eBooks · doi:10.3390/books978-3-03842-972-2
Apolipoprotein Polymorphism and Multifactorial Hyperlipidaemia
Utermann, G. (1988) · Springer eBooks · doi:10.1007/978-94-009-1259-5_7
García‐González, P., Puerta, R., Muñoz-Morales, Á., Olivé, C., Calm, B., Montrreal, L., Valenzuela, A., Bayón-Buján, P., Rovira, M., Capdevila-Bayo, M., et al. (2025) · medRxiv · doi:10.1101/2025.03.25.25324541
Di, C., Tang, T., Wu, H., Gan, J., Shi, Z., Yi, T., Chen, R., Liu, S., & Ji, Y. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251393713
Meuret, C. J., Hu, Y., Smadi, S., Bantugan, M. A., Xian, H., Martinez, A. E., Krauss, R. M., Ma, Q. L., Nedelkov, D., & Yassine, H. N. (2024) · Figshare · doi:10.6084/m9.figshare.26591264
Lu, Q.-X., & Guan, W. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118316
(1988) · PubMed · Cited by 250
Cole (2000) · doi:10.1002/1097-0029(20000815)50:4
Metadata
- Authors
- Gregg, R. E., Zech, L. A., Schaefer, E. J., Stark, D., Wilson, D., & Brewer, H. B.
- Affiliations
- Tufts University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1986-09-01
- Volume
- 78
- Issue
- 3
- Pages
- 815-821
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC423680
- OpenAlex
- W1990170200
- Cited by
- 345
- References
- 27
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 2 · 2021: 4 · 2020: 3 · 2019: 8 · 2018: 7 · 2017: 6 · 2016: 6 · 2015: 3 · 2014: 4 · 2013: 9 · 2012: 8
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- APOE ε4, apolipoprotein E3, APOE polymorphism, plasma residence time, VLDL, high-density lipoprotein, type V hyperlipoproteinemia, hypercholesterolemia, dyslipoproteinemia
- MeSH terms
- Adolescent, Adult, Apolipoproteins E, Female, Homozygote, Humans, Hypercholesterolemia, Hyperlipoproteinemia Type V, Iodine Radioisotopes, Kinetics, Lipoproteins, Lipoproteins, HDL, Lipoproteins, LDL, Lipoproteins, VLDL, Male, Phenotype, Apolipoprotein E3, Apolipoprotein E4, Lipoproteins, IDL
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
